Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma
Clinical trial NCT03250325 · COMPLETED
Trial details
- NCT number
- NCT03250325
- Sponsor
- Takara Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2020-01-23
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.